Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe now
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About Hardman & Co.
Case Studies
Our team
News & events
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Subscribe now
Receive our latest research as soon as it is published
Investment Research & Analysis
Detailed company analysis created for specifically for investors
Tax Enhanced Services
Product reports for investors and advisors
Bespoke Services
Services for clients with specific needs
About Hardman & Co.
We are the longest-established commissioned research provider. Read our story
Case Studies
We help a wide range of clients with different needs. Read what they say about us
Our Team
Meet the Hardman & Co team members
COVID-19: -
Our Commitment to Client Service & Investor Communications
Latest Update
Our research can still be accessed for free under MIFID II.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Utilities
list companies
Diurnal Group Plc
Life Sciences
$52.5m US deal strengthens balance sheet further
By
Dr Martin Hall
30 Mar 2020
Chamberlin Plc
Industrial
Trading stalled in these unprecedented times
By
Paul Singer
30 Mar 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Arix Bioscience
Life Sciences
Fiscal 2019 – moving with the times
By
Dr Dorothea Hill
19 Mar 2020
RM Secured Direct Lending
Investment Companies
Manager presentation at the Hardman & Co Investor Forum
By
Mark Thomas
17 Mar 2020
B-North
Financials
Taking the next steps forward
By
Mark Thomas
13 Mar 2020
Haydale Graphene Industries Plc
Industrial
Cost savings continue, revenue growth encouraging
By
Paul Singer
09 Mar 2020
Allergy Therapeutics plc
Life Sciences
Consistent first-half revenue growth
By
Dr Martin Hall
09 Mar 2020
Pantheon International Plc
Financials
2020 interim results: consistency in delivery
By
Mark Thomas
02 Mar 2020
Primary Health Properties
Property
Final results show accelerating rental growth
By
Mike Foster
28 Feb 2020
Diurnal Group Plc
Life Sciences
… and more to come (news flow)
By
Dr Gregoire Pave
28 Feb 2020
Burford Capital
Financials
Mixture of strong and weak activity in 2019
By
Dr Brian Moretta
26 Feb 2020
1
2
3
...
16
Next
